These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3382171

  • 1. Successful chemotherapy for recurrent malignant oligodendroglioma.
    Cairncross JG, Macdonald DR.
    Ann Neurol; 1988 Apr; 23(4):360-4. PubMed ID: 3382171
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.
    Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R, Nobile M, Rudà R, Borgognone M, Costanza A, Laguzzi E, Mutani R.
    Cancer; 2004 Feb 15; 100(4):807-13. PubMed ID: 14770438
    [Abstract] [Full Text] [Related]

  • 6. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
    Macdonald DR, Gaspar LE, Cairncross JG.
    Ann Neurol; 1990 May 15; 27(5):573-4. PubMed ID: 2360797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
    Buckner JC, Gesme D, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R.
    J Clin Oncol; 2003 Jan 15; 21(2):251-5. PubMed ID: 12525516
    [Abstract] [Full Text] [Related]

  • 9. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P.
    Bull Cancer; 1997 Oct 15; 84(10):951-6. PubMed ID: 9435796
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K, Fukushima T.
    Anticancer Res; 2005 Oct 15; 25(6A):3715-23. PubMed ID: 16302731
    [Abstract] [Full Text] [Related]

  • 11. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D, Sipos L, Vitanovics D.
    Ideggyogy Sz; 2002 Jan 20; 55(1-2):38-44. PubMed ID: 12122942
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
    Brandes AA, Tosoni A, Vastola F, Pasetto LM, Coria B, Danieli D, Iuzzolino P, Gardiman M, Talacchi A, Ermani M.
    Cancer; 2004 Nov 01; 101(9):2079-85. PubMed ID: 15372474
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy: the agents in current use.
    Levin VA, Wilson CB.
    Semin Oncol; 1975 Mar 01; 2(1):63-7. PubMed ID: 795035
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
    Levin VA, Edwards MS, Wright DC, Seager ML, Schimberg TP, Townsend JJ, Wilson CB.
    Cancer Treat Rep; 1980 Mar 01; 64(2-3):237-44. PubMed ID: 7407756
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aggressive oligodendroglioma: a chemosensitive tumor.
    Cairncross JG, Macdonald DR, Ramsay DA.
    Neurosurgery; 1992 Jul 01; 31(1):78-82. PubMed ID: 1641113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.